Asembia's Specialty Pharmacy Summit
Asembia’s Specialty Pharmacy Summit
We’re looking forward to engaging with industry leaders in person at Asembia on April 30–May 4, 2023, in Las Vegas, NV.
Key Considerations to Prepare for Implementation of the IRA’s Drug Pricing Policies
Omar Hafez, Matt Kazan, and Kelsey Lang
Post-Inflation Reduction Act: The Continued Need for Charitable Patient Assistance
Inflation Reduction Act (IRA) Implementation: Inflation-based rebates, Medicare price negotiation, Part D benefit design, and other IRA policies will have a profound impact on healthcare stakeholders. Avalere can help evaluate these policies’ effects and develop strategies for product development and investment decisions, manufacturer contracting strategies, plan formulary and benefit design, and ensuring patient access to medications.
Part D Strategy and Bid Modeling: Part D benefit redesign will add pressure to plans and manufacturers while increasing affordability for beneficiaries. Manufacturers can expect Part D volume and revenue changes and should prepare for new plan approaches to formulary and benefit design. Avalere can be a thought partner to manufacturers developing their strategy for engaging Part D plans for 2025 using qualitative and quantitative approaches.
Health Equity’s Role in Access: Abundant evidence shows persistent inequities in diagnosis, treatment, and outcomes experienced by consistently marginalized groups. Avalere takes a data-driven approach to pinpoint key drivers of those inequities, such as treatment variations, differential access to services and treatments, or social determinant factors such as affordability, transportation, and caregiver support.
The Avalere experts below will attend Asembia’s 2023 Specialty Pharmacy Summit. Connect with them and see how Avalere can help your business.
Read Our Take on Top Trends
Continued shifts in Medicare Advantage enrollment introduce new value-based care opportunities for p...
Patient-Centered Research & Outcomes
Gain insights needed to drive organizational goals while improving patient experiences and outcomes.
Market Access and Commercialization
We help life sciences companies successfully initiate and sustain product commercialization.
Federal and State Healthcare Policy Consulting
We provide clients with multistakeholder perspectives on federal and state healthcare policy to help them navigate the complex legislative and regulatory environment.